After Bonferroni correction for multiple testing, the serum levels of adiponectin were significantly negatively correlated with the serum levels of cholesterol (VLDL-C), free cholesterol (VLDL-FC), triglycerides (VLDL-TG), phospholipids (VLDL-PL), and apolipoprotein (apo) B (VLDL-apoB) in total VLDL, as well as in the large buoyant VLDL subclasses 1–3 (with the exception of VLDL2-C) in HVs, but not in patients with MS (Table 3). This evidence concerns the gene ADIPOQ and myeloid sarcoma.